UCSF Medical Center, a top-tier institution with an established brain radio-surgery programme, has signed an agreement to acquire the CyberKnife through the CyberKnife Placement Model (CPM), a revenue and risk-sharing joint venture with Accuray, in order to expand its radio-surgery programme. Mitchel Berger, M.D., Professor and Chairman of Neurosurgery at UCSF, stated: "I am pleased that UCSF Medical Center has decided to acquire a CyberKnife and is following the vision that Dr. John Adler, M.D., founder and CEO of Accuray, and I have had of expanding radio-surgery beyond the brain."
David Larson, M.D. Ph.D. and William Wara, M.D., Department of Radiation Oncology, agreed. "What makes the CyberKnife unique is that it uses an image-guidance system which relies on the skeletal system for stereotaxy instead of an unwieldy and uncomfortable immobilisation system. Through the elimination of external localising devices, this system will potentially enable physicians to use external radio-surgery for the first time to treat tumours with great accuracy throughout the body and with confidence that patient motion is accounted for."
In turn, MedStar Health, the largest health care system in the Baltimore-Washington, D.C. region, has obtained the $2.9 million CyberKnife for its Lombardi Cancer Center at Georgetown University Hospital, one of the top cancer centres in the United States. Steven S. Cohen, Senior Vice President of Integrated Operations at MedStar Health, commented: "This type of technical innovation is evidence of why our hospitals are nationally ranked and why we are the health care provider of choice in this region. From now on, patients in our network will have a non-invasive treatment option for certain cancers of the brain and spine."
Thierry Thaure, Senior Vice President of Sales and Marketing at Accuray, concluded: "The outright purchase of the $2.9 million CyberKnife system for Georgetown University Hospital, owned and operated by MedStar Health, and UCSF Medical Center's acquisition through the CyberKnife Placement Model are examples of the flexibility we can offer customers. With over 1.2 million new cases of cancer diagnosed in the United States alone last year, this has the potential to be a high impact technology for patients around the world."
Accuray Incorporated is a privately held corporation located in California, in the heart of the Silicon Valley. The company has as its mission to enable full-body radio-surgery with use of image-guided robotics and to make this technology available to physicians throughout the world. You can find more details about CyberKnife in this issue's VMW article Non-invasive CyberKnife technology successfully tested in lung tumour therapy with image-guided radio-surgery.